Partnering with Big Pharma—What Academics Need to Know

Knowledge of the parameters of drug development can greatly aid academic scientists hoping to partner with pharmaceutical companies. Here, we discuss the three major pillars of drug development—pharmacodynamics, pharmacokinetics, and toxicity studies—which, in addition to pre-clinical efficacy, are critical for partnering with Big Pharma to produce novel therapeutics.